Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy (semaglutide) is a once-weekly injection, not a daily medicine — so if you've searched 'daily chemist Wegovy', you may be wondering whether it's available from a chemist like Daily Chemist, how the prescription process works, or simply what Wegovy actually involves. It's a prescription-only medicine in the UK, which means a qualified prescriber must assess your suitability before any supply. This page walks you through the real process, what to expect at each step, and how to make sure any pharmacy you use is properly regulated.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Wegovy is the brand name for semaglutide at weight-management doses, made by Novo Nordisk. It works by activating GLP-1 receptors involved in appetite signalling and gastric emptying, which reduces how hungry you feel and slows how quickly your stomach empties after eating. You can read more about how semaglutide works at a molecular level if the mechanism interests you, but for most people the practical point is simpler: appetite falls, portion sizes follow, and weight tends to reduce over time.
The standard maintenance dose is 2.4mg weekly, reached in gradual steps from 0.25mg. A 7.2mg maintenance dose was approved by the MHRA in early 2026, with a dedicated single-dose pen confirmed in April 2026, for adults with a BMI of 30 or above. Throughout treatment the prescriber decides timing and dose, not the patient, and not the pharmacy. The full picture on whether Wegovy is taken daily or weekly is worth reading if you're still unsure about the schedule.
One practical note on timing: if you're planning treatment around a holiday or a month where payday falls late, it's worth building in a few extra days for clinical review and delivery rather than ordering at the last minute. Most regulated services, including regulated online pharmacies, depend on a prescriber being available to review your case, and public holidays can affect turnaround.
Because Wegovy is a POM, the legal route to obtaining it is a prescription issued by a qualified prescriber after a proper clinical assessment. That assessment covers your BMI, any weight-related health conditions, your medical history, current medicines, and whether there are any reasons Wegovy would not be appropriate for you. A pharmacy dispenses against that prescription, it does not make the prescribing decision itself.
When you're looking at online pharmacies, the single most important check is whether they appear on the GPhC register. The General Pharmaceutical Council lists every registered pharmacy in England, Scotland and Wales; you can search the GPhC register directly to confirm a pharmacy's registration before you share any personal information or pay anything. Sellers who offer these medicines without requiring a full clinical assessment, or who seem to bypass that step, are operating outside UK law. The MHRA has warned repeatedly about counterfeit weight-loss pens sold through unverified channels, fake pens have contained the wrong active substance entirely.
If you want to compare the general Chemist for You Wegovy route with other options, that page covers the same ground for a different provider.
Wegovy is licensed for adults aged 18 and over with a BMI of 30 or above, or 27 to 29.9 with at least one qualifying weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol or obstructive sleep apnoea. Lower thresholds apply for some ethnic backgrounds under UK guidance. BMI alone doesn't decide the outcome; the prescriber looks at the full clinical picture, and certain conditions (including a personal or family history of medullary thyroid carcinoma, or a history of pancreatitis) would prompt careful discussion or mean Wegovy isn't suitable. The NHS semaglutide page lists the full contraindications and interactions in plain language.
Side effects are mostly gastrointestinal, particularly in the first few weeks: nausea, constipation, loose stools, reflux and fatigue are reported most often. They tend to ease as the body adjusts, and are usually most noticeable after starting or stepping up to a new dose. Severe, persistent stomach pain that radiates to the back needs prompt medical attention, this is the symptom profile associated with pancreatitis, which is a known but infrequent risk the MHRA flagged in a Drug Safety Update. More detail on Wegovy's side-effect profile is available if you want to go deeper before deciding.
After the prescription is issued, ongoing supply depends on clinical re-review. A legitimate service will check in before each repeat, confirming that treatment is still appropriate and that your weight and health picture support continuing. Aftercare is part of the process, not an optional extra. If you're at the early stages of research, our Wegovy overview page covers the wider picture, and a sense of what Wegovy costs privately in the UK helps set expectations before you start.
At nume, every consultation is read by a GPhC-registered Independent Prescriber) a real clinician reviewing your responses, not an automated filter passing you through. Identity is verified with photo ID, and weight is confirmed on a live video call. If your case is clinically suitable and you order before midday on a working day, treatment is dispatched the same day and delivered free the next working day by DPD, in plain packaging. GPhC premises registration 9012878 is verifiable at the GPhC register.
The single price covers consultation, prescription, treatment and delivery. There are no subscription commitments and no auto-renewals; every repeat order goes through clinical review again. Aftercare is available seven days a week. If you'd like to check whether you're likely to be eligible, the right place to start is a free consultation with our prescribers, no obligation, no upfront payment before you know where you stand.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.